Skip to main content

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Brand names: AlleRx Dose Pack

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Pregnancy Warnings

Chlorpheniramine/methscopolamine/PE/PSE has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/PE/PSE is only recommended for use during pregnancy when benefit outweighs risk.

See references

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of chlorpheniramine/methscopolamine/PE/PSE into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Chlorpheniramine/methscopolamine/phenylephrine/pseudoephedrine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. "Product Information. AlleRx Dose Pack (chlorpheniramine/methscopolamine/PE/PSE)." Cornerstone Therapeutics

References for breastfeeding information

  1. "Product Information. AlleRx Dose Pack (chlorpheniramine/methscopolamine/PE/PSE)." Cornerstone Therapeutics

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.